Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
September 22, 2026
SweetSpot Health Review 2026: Services, Pricing and What to Know
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber. Published pricing: SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. This independent directory review evaluates public information, not medical outcomes. We did not purchase the service or test medication. Eligibility, prices and terms may change; verify them directly before making a care decision.
Quick verdict
Independent review of
SweetSpot Health
5.9/10 our score
- Best for
- diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data
- Key feature
- SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber.
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber. Published pricing: SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. This independent directory review evaluates public information, not medical outcomes. We did not purchase the service or test medication. Eligibility, prices and terms may change; verify them directly before making a care decision.
Our rating
Pros and cons
Pros
- diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data
- The company publishes a service description that informs pre-enrollment questions.
- Virtual or integrated care may be convenient for eligible users.
Cons
- Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership.
- SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price.
- Public information does not guarantee individual eligibility or outcomes.
Full review
- Our score
- 5.9/10
- Best for
- diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data
- Published pricing
- SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price.
- Customer feedback
- No matching Trustpilot score independently verified for this specific service.
Quick verdict
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber. Published pricing: SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. This independent directory review evaluates public information, not medical outcomes. We did not purchase the service or test medication. Eligibility, prices and terms may change; verify them directly before making a care decision. This score reflects the clarity of public information and the apparent consumer service design. It is not an assessment of clinical effectiveness or an endorsement.
What SweetSpot Health offers
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber.
For a healthcare service, read who actually provides clinical care, whether the platform is the provider or an administrative company, which state-licensed clinician reviews the case, and what happens after the first consultation. A branded website can coordinate care without itself being the professional practice. This distinction matters for records, prescriptions, follow-up, complaints and billing.
Pricing and billing
SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. The complete price can vary by eligibility, health plan, prescription, dose, lab work, shipping, professional fees or follow-up schedule. Treat a promotional starting price as a starting point only.
| Before enrolling | Confirm directly |
|---|---|
| Consultation and membership | One-time or recurring charge, billing date and renewal. |
| Medication, equipment or labs | Whether separately billed, by whom, and how the price changes by dose, pharmacy or coverage. |
| Benefits and eligibility | Whether your employer, health plan or state makes you eligible; check member cost-sharing. |
| Cancellation and refunds | Notice period, order status, prorating and any guarantee exclusions. |
Care model, eligibility and scope
Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership. Ask whether visits are live, asynchronous or both; how quickly clinicians answer messages; how often follow-ups occur; and what emergency or adverse-event route the company recommends. If a medication is prescribed, ask for the prescriber and pharmacy details, written instructions and the process for refills.
Safety and evidence
Do not treat testimonials, marketing claims or an editorial directory score as proof that a treatment is safe or effective for you. A licensed clinician who knows your medical history should discuss potential benefits, contraindications, interactions, monitoring and alternatives. Compounded prescription medicines are not FDA-approved products; when relevant, confirm the specific pharmacy, why the clinician considers compounding appropriate, and the product’s storage and beyond-use instructions. Do not start, stop or change a prescription based on a review article.
Pros and cons
Potential advantages
- diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data
- The company publishes a service description that can help consumers ask focused questions.
- Virtual or integrated support may reduce practical friction for people who are eligible.
Limitations to check
- Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership.
- SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price.
- Public information does not establish patient outcomes or guarantee service availability in every state.
Our rating
We use a consistent directory rubric: cost and price transparency (30%), medication or service clarity (20%), clinical care and safety disclosures (20%), ease of access (15%), and customer support and policy clarity (15%). These are editorial scores for the visible service model, not clinical quality ratings.
| Category | Score | Weight | What we evaluated |
|---|---|---|---|
| Cost and price transparency | 7.0/10 | 30% | Based on public disclosures and the service model described in linked sources. |
| Medication options and sourcing | 2.0/10 | 20% | Based on public disclosures and the service model described in linked sources. |
| Medical care and safety | 7.0/10 | 20% | Based on public disclosures and the service model described in linked sources. |
| Ease of use and access | 6.0/10 | 15% | Based on public disclosures and the service model described in linked sources. |
| Customer support and policies | 7.0/10 | 15% | Based on public disclosures and the service model described in linked sources. |
Weighted editorial score: 5.9/10. We show the category scores and weights so readers can see what drove the result.
Customer reviews
We did not find and independently verify a Trustpilot profile clearly attributable to this exact service during this review. No Trustpilot rating or review count is displayed. Check current consumer feedback with care, confirm it refers to the same company, and remember that review platforms are self-selected and cannot verify treatment outcomes.
How it compares
| Decision point | SweetSpot Health | Other routes |
|---|---|---|
| Care model | SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber. | Compare with a local clinician, insurer network, employer benefit or dedicated specialist clinic. |
| Price | SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. | Compare the full expected cost over the same period and include pharmacy, visits, labs and supplies. |
| Ongoing support | Verify the actual follow-up schedule and who responds to clinical questions. | Ask other services the same questions before judging convenience or continuity. |
| Best fit | diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data | Choose based on eligibility, clinical needs, coverage, location and preferences. |
Frequently asked questions
What is SweetSpot Health?
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber.
How much does it cost?
SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. Ask for the total for the plan that applies to you, including recurring charges and any separate pharmacy or provider costs.
Is it available to everyone?
Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership. Services and clinician availability can vary by location and eligibility.
Does a consultation guarantee a prescription or outcome?
No. A qualified clinician must decide whether a treatment is appropriate. No service can responsibly guarantee an individual medical outcome.
Sources
We reviewed the official and other clearly identified public sources below on September 24, 2026. A linked page documents the provider’s stated terms; it is not independent verification of clinical outcomes.
How we researched and scored
We reviewed linked public service descriptions, eligibility, price disclosures and policy information. We did not purchase the service, submit a personal health intake, test a product or conduct medical testing. When a third-party listing is included, it is labelled and should be verified with the provider. Scores may change when public terms change.
Final verdict
SweetSpot Health may suit diabetes clinics and practices seeking one view of patients’ CGM and insulin-pump data. Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership. Before enrolling, confirm the current written price, eligibility, care provider, service scope, support access and cancellation terms. For treatment decisions, consult a qualified professional who can assess your individual health history.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
September 22, 2026
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
September 22, 2026
Frequently asked questions
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber.
SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price.
Best assessed as a provider-side tool; individual patients generally interact through their care team, and access depends on a clinic partnership.
No. A qualified clinician decides if treatment is appropriate.
Sources
- SweetSpot platform www.sweetspot.health · checked September 24, 2026
- SweetSpot for patients www.sweetspot.health · checked September 24, 2026
- SweetSpot clinical support www.sweetspot.health · checked September 24, 2026
User reviews
No user reviews yet.
How we test
TirzaSema GLP-1 Provider Scoring Methodology
This methodology explains how TirzaSema scores GLP-1 telehealth providers and programs. Scores are a weighted average of five categories, and every review shows the full breakdown. Affiliate relationships and commission rates are not part of the methodology.
- Features · 25%
- Performance · 25%
- Ease of use · 15%
- Value for money · 20%
- Customer support · 15%
Prices are collected from each provider's public pricing pages and, where possible, confirmed during sign-up. Medication and membership costs are recorded separately, prices are shown by dose where published, introductory offers are labeled, and every price carries the date it was checked. When a review is based on hands-on testing we describe exactly what we did; when it is based on public information only, we say so.
FDA-approved medications themselves are not scored. They are listed as reference entries with their FDA-labeled uses and official manufacturer prices.
Some links on TirzaSema are affiliate links. Commissions never affect scores, rankings, pros and cons, or medical and regulatory information. See our Affiliate Disclosure.
Final verdict
SweetSpot is a diabetes data-management and remote-care platform for healthcare practices. Its software consolidates continuous-glucose-monitor and insulin-pump data, while its clinical-support team helps partner practices monitor patients and coordinate follow-up. It is not a weight-loss clinic or consumer GLP-1 prescriber. Published pricing: SweetSpot states there is no setup fee or monthly subscription fee for practice partners; the public site does not publish a complete commercial rate card or a consumer price. This independent directory review evaluates public information, not medical outcomes. We did not purchase the service or test medication. Eligibility, prices and terms may change; verify them directly before making a care decision.
T
Written by
TirzaSema Editorial Team
Research and editorial team
The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…